Chemotherapy Combined with Involved‐Field Radiotherapy for 177 Children with Hodgkin's Disease Treated in 1983–1987

Paediatric oncology and haematology in Poland: position paper

“…At the same time, supportive care was improved. The use of combined-modality therapy resulted in the cure of about 90% of children [31,32]. However, the intensive treatment increased the risk of late complications, especially second malignancies.…”

Childhood stage IV Hodgkin disease: Therapeutic results of the Polish Pediatric Leukemia/Lymphoma Study Group

“…In the first period the predominant involvement of extralymphatic organs was in the liver, whereas in the third period the lungs were most frequently affected, considerably more often than the liver, bone marrow, and other organs (Table I) [12,13,22,23].…”

“…Therapeutic protocols developed in 1969 by the Department of Pediatric Hematology in Kraków [22] were accepted by the other centers of Polish Pediatric Leukemia/Lymphoma Study Group (PPLLG), and after several modifications they are still in use [13]. Changes in staging and treatment as well as the therapeutic results (approximately 90% cure rate) in children with all stages of HD have been presented elsewhere [12,13,23]. In this paper, we present data on our patients with stage IV HD.…”

Autologous and Allogeneic Cellular Therapies for High-risk Pediatric Solid Tumors

“…Poor prognosis in these relapsed patients is associated with chemotherapy resistant disease, short time to relapse (less than one year) and extra nodal disease at relapse as well as poor performance status in adult patients[7–8]. …”